Emily Chee

General Manager, Americas • Novartis

Emily Chee is the General Manager – Americas for Novartis Gene Therapies.  She has responsibility for the business in the US where Zolgensma was launched in 2019 as well as Canada and Latin America.  Emily has worked with Novartis for close to two decades focused on the Oncology business until two years ago when she shifted to Gene Therapies.  She has also served many Big Pharma and Biotech clients as a management consultant prior to joining Novartis

Also Speaking

Marc Wolfgang

Vice President of Technical Development • BioNTech

Ronit Slotky

Director, Cell Therapy Manufacturing Facility • Hackensack University Medical Center

Dan Strange

Chief Technology Officer • Cellular Origins, A TTP Company

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.